Since 1971, Lindora has offered eligible clients prescription medication as additional support. The latest innovation in weight loss medicines are GLP-1 weekly injections.
GLP-1s mimic the action of naturally occurring peptides, stimulating the production of both glucagon and insulin to help regulate blood sugar and feel fuller, and curb cravings to support your weight loss and lifestyle changes.
At Lindora, our GLP-1s injections are medically supervised and administered by our nurse to help you achieve your goal with proper titration to help minimize side effects.* Our GLP-s are paired with a Wellness Membership that includes 1:1 nutrition coaching to help you maintain lean muscle and proper nutrition throughout your program.
*Prescription products are only available if prescribed by a qualified healthcare provider after consultation. Individual results may vary and are not guaranteed.
GLP-1s mimic the action of a naturally occurring peptide called glucagon-like peptide 1. This hormone is produced in the gut in response to food, and stimulates the production of both glucagon and insulin to regulate blood sugar levels.
GLP-1 injections act on appetite centers in the brain to increase a feeling of fullness and to slow the emptying of the stomach-causing you to eat less at meals and snack less between, allowing you to make behavioral lifestyle change to keep the weight off for good.
Lindora has always been at the forefront of weight loss and metabolic health. As Chief Medical Officer, Dr. Kamelia Kashani leads our mission to empower clients with science-based, personalized wellness solutions that support healthier, longer lives.
A double board-certified physician in Obesity Medicine and Family Medicine, Dr. Kashani has over 20 years of experience helping thousands of patients optimize their metabolic health, manage weight, and prevent chronic disease through nutrition, lifestyle interventions, and evidence-based medical care.
*Prescription products are only available if prescribed by a qualified healthcare provider after consultation. Individual results may vary and are not guaranteed. Semaglutide and Tirzepatide are compounded products and have not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs.